Anemone Franz is a physician with a background in global health and infectious diseases. She works as an advisor for 80,000 Hours, where she focuses on biosecurity. Previously, she worked as a clinical trial physician for Alvea, a start-up company aiming to accelerate the development and deployment of medical countermeasures for pandemics.
Content by Anemone Franz
To better understand emerging technologies, NEVER members Konrad, Anemone, Emil, Arthur, and Joel outline the evolution of the risk landscape around emerging disruptive technologies and draw parallels between the dangers posed by nuclear weapons and those posed by novel biotechnologies. They explore the broader challenge of governing emerging technologies and suggest potential ways forward.